首页> 外文会议>Gastrointestinal Cancers Symposium >Liver-Directed Therapies for Primary and Metastatic Disease: Radioembolization and Chemoembolization
【24h】

Liver-Directed Therapies for Primary and Metastatic Disease: Radioembolization and Chemoembolization

机译:肝脏定向治疗原发性和转移性疾病:放射性栓塞和化疗栓塞

获取原文

摘要

Anatomically targeted treatments for focal tumors have been a mainstay of oncologic treatment for generations. Surgical resection and radiotherapy are frequently not feasible for hepatic malignancies, though, where multifocality, compromised liver function, and hepatic radiosensitiv-ity limit the applications of these options. By exploiting the dual blood supply to the liver with preferential arterial (vs. portal venous) supply to malignancies, high dose chemotherapy, or radiation may be delivered in an anatomically and physiologically targeted fashion via the intra-arterial route to intrahepatic tumors, with limited systemic and organic toxicity. Indications, patient selection, treatment algorithms, agents, and vehicles continue to evolve.
机译:对局灶性肿瘤的解剖学靶向治疗是几代人的肿瘤治疗的主要疗法。虽然多焦度,受损的肝功能和肝脏辐射敏感度 - ITY限制了这些选择的应用,但外科切除和放射疗法通常不可行。通过利用对恶性肿瘤的优先动脉(与门静脉)供应的优先动脉(与门静脉),高剂量化疗或辐射来利用肝脏的双血供应,可以通过动脉内途径到肝内肿瘤,有限的情况下以解剖学和生理靶向的方式递送系统性和有机毒性。适应症,患者选择,治疗算法,药剂和车辆继续发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号